Impact of Optimal Therapy and Prognostic Factors in Malignant Germ Cell Tumors of Ovary: 20 Years’ Institutional Experience

[1]  M. Frey,et al.  Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors , 2018, International Journal of Gynecologic Cancer.

[2]  I. Ray-Coquard,et al.  Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Sameer Gupta,et al.  Germ Cell Tumor Ovary: an Institutional Experience of Treatment and Survival Outcomes , 2018, Indian Journal of Surgical Oncology.

[4]  Yong-Man Kim,et al.  Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors. , 2017, Gynecologic oncology.

[5]  A. Gadducci,et al.  The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  M. Bilgin,et al.  Long‐term oncological and reproductive outcomes of fertility‐sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors , 2014, The journal of obstetrics and gynaecology research.

[7]  S. Fosså,et al.  Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009). , 2013, Gynecologic oncology.

[8]  M. Geraci,et al.  Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003 , 2012, Cancer.

[9]  D. Gershenson.  Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary. , 2012, Gynecologic oncology.

[10]  G. Gatta,et al.  Rare cancers are not so rare: the rare cancer burden in Europe. , 2011, European journal of cancer.

[11]  Keun Ho Lee,et al.  Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institution , 2011, World journal of surgical oncology.

[12]  A. Gadducci,et al.  Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors: A MITO-9 Retrospective Study , 2011, International Journal of Gynecologic Cancer.

[13]  N. Hacker,et al.  Berek & Hacker's gynecologic oncology , 2010 .

[14]  J. Chan,et al.  The influence of conservative surgical practices for malignant ovarian germ cell tumors , 2008, Journal of surgical oncology.

[15]  Y. Salihoğlu,et al.  Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence. , 2008, European journal of gynaecological oncology.

[16]  K. Ushijima,et al.  Fertility‐preserving treatment for patients with malignant germ cell tumors of the ovary , 2006, The journal of obstetrics and gynaecology research.

[17]  C. Muller,et al.  Incidence and Survival Rates for Female Malignant Germ Cell Tumors , 2006, Obstetrics and gynecology.

[18]  W. London,et al.  Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. , 2004, Journal of pediatric surgery.

[19]  H. Howe,et al.  Ovarian cancer in children and young adults in the United States, 1992–1997 , 2003, Cancer.

[20]  P. Shashikala,et al.  Germ cell tumors of the ovary: Is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors? , 2001, International Journal of Gynecologic Cancer.

[21]  F. Kikkawa,et al.  Prognostic factors of patients with yolk sac tumors of the ovary. , 2001, American journal of obstetrics and gynecology.

[22]  H. Kuramoto,et al.  Conservative surgery for malignant ovarian tumor in women of childbearing age , 2000, International Journal of Clinical Oncology.

[23]  P. Disaia,et al.  Malignant Germ Cell Tumors of the Ovary , 2000, Obstetrics and gynecology.

[24]  J. Nicklin,et al.  Fertility and Ovarian Function After Conservative Surgery for Germ Cell Tumours of the Ovary , 1999, The Australian & New Zealand journal of obstetrics & gynaecology.

[25]  A. Ayhan,et al.  Malignant germ cell tumors of the ovary: Hacettepe hospital experience , 1995, Acta obstetricia et gynecologica Scandinavica.

[26]  N. Nakashima,et al.  Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases , 1991, Cancer.

[27]  D. Grimes,et al.  Relative frequency of primary ovarian neoplasms: A 10‐year review , 1989, Obstetrics and gynecology.